Publication:
In vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation.

dc.contributor.authorOrrantia, Ane
dc.contributor.authorVázquez-De Luis, Enrique
dc.contributor.authorAstarloa-Pando, Gabirel
dc.contributor.authorTerrén, Iñigo
dc.contributor.authorAmarilla-Irusta, Ainhoa
dc.contributor.authorPolanco-Alonso, Diego
dc.contributor.authorGonzález, Carmen
dc.contributor.authorUranga, Alasne
dc.contributor.authorCarrascosa, Tomás
dc.contributor.authorMateos-Mazón, Juan J
dc.contributor.authorGarcía-Ruiz, Juan C
dc.contributor.authorCallejas, Sergio
dc.contributor.authorQuintas, Ana
dc.contributor.authorDopazo, Ana
dc.contributor.authorZenarruzabeitia, Olatz
dc.contributor.authorBorrego, Francisco
dc.contributor.funderAsociación Española Contra el Cánceres_ES
dc.date.accessioned2023-11-06T11:29:27Z
dc.date.available2023-11-06T11:29:27Z
dc.date.issued2022-10-21
dc.description.abstractAutologous hematopoietic stem cell transplantation (autoHSCT) is a treatment option for hematological disorders and pediatric solid tumors. After an autoHSCT, natural killer (NK) cells are the first lymphocyte subset returning to normal levels. To uncover global changes during NK cell reconstitution after autoHSCT, we performed RNA-sequencing on NK cells before and after autoHSCT. Results showed profound changes in the gene expression profile of NK cells immediately after autoHSCT. Several biological processes including cell cycle, DNA replication and the mevalonate pathway were enriched. Significantly, we observed that following autoHSCT, NK cells acquired a decidual-like gene expression profile, including the expression of CD9. By using multiparametric flow cytometry, we confirmed the expansion of NK cells expressing CD9 immediately after autoHSCT, which exhibited higher granzyme B and perforin expression levels than CD9- NK cells. These results provide insights into the physiopathology of NK cells during their reconstitution after autoHSCT.es_ES
dc.description.peerreviewedes_ES
dc.description.sponsorshipSupported by the following grants: AECC-Spanish Association Against Cancer (PROYE16074- BORR) and Health Department, Basque Government (2021333006). GA-P is the recipient of a predoctoral contract funded by AECC-Spanish Association Against Cancer (PRDVZ21440ASTA). DP-A is a recipient of a fellowship from the AECC-Spanish Association Against Cancer (PPLAB212164POLA), AA-I and GA-P are recipient of a fellowship from the Jesús de Gangoiti Barrera Foundation (FJGB20/007, FJGB21/001 and FJBG21/005). IT is recipient of a predoctoral contract funded by the Department of Education, Basque Government (PRE_2021_2_0215). OZ is the recipient of a postdoctoral contract funded by ‘‘Instituto de Salud Carlos III-Contratos Sara Borrell 2017 (CD17/00128)’’ and the European Social Fund (ESF)-The ESF invests in your future. FB is an Ikerbasque Research Professor, Ikerbasque, Basque Foundation for Science.es_ES
dc.format.number10es_ES
dc.format.page105235es_ES
dc.format.volume25es_ES
dc.identifier.citationiScience. 2022 Sep 28;25(10):105235.es_ES
dc.identifier.doi10.1016/j.isci.2022.105235es_ES
dc.identifier.e-issn2589-0042es_ES
dc.identifier.journaliSciencees_ES
dc.identifier.pubmedID36262311es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/16640
dc.language.isoenges_ES
dc.publisherCell Presses_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PROYE16074-BORRes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/2021333006es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PRDVZ21440ASTAes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PPLAB212164POLAes_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FJGB20/007es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FJGB21/001es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/FJBG21/005es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/PRE_2021_2_0215es_ES
dc.relation.projectFECYTinfo:eu-repo/grantAgreement/ES/CD17/00128es_ES
dc.relation.publisherversion10.1016/j.isci.2022.105235es_ES
dc.repisalud.institucionCNICes_ES
dc.repisalud.orgCNICCNIC::Unidades técnicas::Genómicaes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAttribution-NonCommercial-NoDerivatives 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.titleIn vivo expansion of a CD9+ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation.es_ES
dc.typejournal articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication068a8db5-304f-4b6c-959e-8c920b204eff
relation.isAuthorOfPublication90c95c5b-73c0-44ee-8f23-a0d92a30c789
relation.isAuthorOfPublication.latestForDiscovery068a8db5-304f-4b6c-959e-8c920b204eff

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
In vivo expansion of a CD9_iScience_2022.pdf
Size:
2.89 MB
Format:
Adobe Portable Document Format
Description:
Artículo